ArticleOpen forum infectious diseases2022
Metrics for Phased Prevention of Coronavirus Disease 2019 Transmission for Institutions of Higher Education: 2022 and Beyond.
Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the nearly 2 years since suspending in-person activities, many institutions of higher education (IHEs) have struggled with returning students, staff, and faculty to campus safely and developed robust mitigation plans, continuing or instituting surveillance testing, and codifying stringent coronavirus disease 2019 codes of conduct. Essential to return-to-campus planning is a strategy for when and how to reduce activities to slow transmission through phased prevention-a strategy for reintroducing nonpharmaceutical interventions and "metering" activities at IHEs based on the levels of community severe acute respiratory syndrome coronavirus 2 transmission and testing. In this regard, I propose a series of mitigation measures and the metrics for their implementation, color coded and categorized in phases similar to those recommended by the federal and numerous state governments to open nonessential businesses and resume in-person services, and specific where applicable to IHEs that require vaccination and those at which vaccination is optional.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.